RETROSPECTIVE VALIDATION OF A METAGENOMIC SEQUENCING PROTOCOL FOR COMBINED DETECTION OF RNA AND DNA VIRUSES USING RESPIRATORY SAMPLES FROM PEDIATRIC PATIENTS.
Viruses are the main cause of respiratory tract infections. Metagenomic next-generation sequencing (mNGS) enables the unbiased detection of all potential pathogens. To apply mNGS in viral diagnostics, there is a need for sensitive and simultaneous detection of RNA and DNA viruses. In this study, the performance of an in-house mNGS protocol for routine diagnostics of viral respiratory infections with potential for automated pan-pathogen detection was studied. The sequencing protocol and bioinformatics analysis were designed and optimized including exogenous internal controls. Subsequently, the protocol was retrospectively validated using 25 clinical respiratory samples. The developed protocol using Illumina Nextseq 500 sequencing showed high repeatability. The use of NCBI's RefSeq database as opposed to NCBI's nucleotide database led to enhanced specificity of classification of viral pathogens. A correlation was established between read counts and PCR cycle threshold value. Sensitivity of mNGS, as compared to PCR, varied up to 83% with specificity of 94% respectively, dependent on the cut-off for defining positive mNGS results. Viral pathogens only detected by mNGS, not present in the routine diagnostic workflow were influenza C, KI polyomavirus, cytomegalovirus and enterovirus. Sensitivity and analytical specificity of this mNGS protocol was comparable to PCR and higher when considering off-PCR target viral pathogens. All potential viral pathogens were detected in one single test, while it simultaneously obtained detailed information on detected viruses.